Orchard achieves $1.2B valuation with $200M IPO

Orchard Therapeutics Ltd. (NASDAQ:ORTX) raised $200 million on Oct. 31 in an IPO that priced at the bottom of its proposed range, but sold more ADSs than proposed. The IPO price

Read the full 314 word article

How to gain access

Continue reading with a
two-week free trial.